REG - Aptamer Group PLC - Posting of Circular and Notice of General Meeting

AptamerAnnouncement

24/07/2024 18:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240724:nRSX7290Xa&default-theme=true

RNS Number : 7290X  Aptamer Group PLC  24 July 2024

24 July 2024

 

Aptamer Group plc

 

("Aptamer", the "Company" or the "Group")

 

Posting of Circular and Notice of General Meeting

 

Aptamer Group plc (AIM: APTA), the developer of novel Optimer® binders to
enable innovation in the life sciences industry, announces further to the
announcement made earlier today relating to its proposed Firm Placing,
Conditional Placing and Subscription to raise approximately £2.83 million
("Announcement"), that it has despatched the Circular and Notice of General
Meeting to Shareholders.

The Directors confirm they are to convene a General Meeting of the Company at
11:00 a.m. on Tuesday 13 August 2024 at Windmill House, Innovation Way, York,
YO10 5BR.

The Circular and Notice of General Meeting is available on the Company's
website at https://aptamergroup.com/investors/reports-and-presentations/
(https://aptamergroup.com/investors/reports-and-presentations/)

The results of voting on all resolutions at the General Meeting will be
announced via a Regulatory News Service and the full results of the voting
will be published on the Company's website, as soon as practicable after the
conclusion of the General Meeting.

 

Capitalised terms used but not otherwise defined in this announcement shall
have the meanings ascribed to such terms in the Announcement, unless the
context requires otherwise.

 

- ENDS -

 

For further information, please contact:

 

 Aptamer Group plc                                         +44 (0) 1904 217 404

 Dr Arron Tolley

 SPARK Advisory Partners Limited - Nominated Adviser       +44 (0) 20 3368 3550

 Andrew Emmott / Adam Dawes

 Turner Pope Investments (TPI) Limited - Broker            +44 (0) 20 3657 0050

 James Pope / Andrew Thacker

 

About Aptamer Group plc

Aptamer (http://www.aptamergroup.com/)  Group develops custom affinity
binders through its proprietary Optimer® platform to enable new approaches
in therapeutics, diagnostics, and research applications. The Company strives
to deliver transformational solutions that meet the needs of life science
researchers and developers through the use of its
proprietary Optimer® platform.

Optimer® binders are oligonucleotide affinity ligands that can function as
an antibody alternative. The global affinity ligand market is currently worth
over $170 billion. Optimer® binders are engineered to address many of the
issues found with alternative affinity molecules, such as antibodies, and
offer new, innovative solutions to bioprocessing, diagnostic and
pharmaceutical scientists.

Aptamer has successfully delivered projects for global pharma companies,
diagnostic development companies and research institutes covering a range of
targets and applications with the objective of establishing royalty-bearing
licenses. Through the unique Optimer® technology and processes, scientists
and collaborators can make faster, more informed decisions that support
discovery and development across the Life Sciences.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NOGBRGDRGBDDGSS